Holen Sie sich die Stockscreener-App
8.35
1.30%
-0.11
Handel nachbörslich:
8.42
0.07
+0.84%
Eupraxia Pharmaceuticals Inc Aktie (EPRX) Neueste Nachrichten
Is HBOS plc Preferred Security forming a double bottomWeekly Earnings Recap & Real-Time Price Movement Reports - baoquankhu1.vn
(EPRX.WT.A) Advanced Trading Insights - Stock Traders Daily
Eupraxia Pharmaceuticals (TSX:EPRX) Trades With S&P/TSX Index - Kalkine Media
Here's Why We're Not At All Concerned With Eupraxia Pharmaceuticals' (TSE:EPRX) Cash Burn Situation - Yahoo Finance
(EPRX) Optimized Trading Opportunities (EPRX:CA) - Stock Traders Daily
(EPRX.WT.A) Trading Strategy and Analysis - Stock Traders Daily
(EPRX) Market Performance Analysis (EPRX:CA) - Stock Traders Daily
Fed Watch: Will Eupraxia Pharmaceuticals Inc stock hit new highs in YEAR - baoquankhu1.vn
(EPRX.WT.A) Investment Analysis (EPRX.WT.A:CA) - Stock Traders Daily
(EPRX) Technical Data (EPRX:CA) - Stock Traders Daily
Osteoarthritis Pipeline 2025: MOA and ROA Insights, Clinical Trials Status, and Key Companies Involved by DelveInsight | Merck, Peptinov, LG Chem, Akan Bioscience, BioTissue,Inc., Eupraxia Pharma - Barchart.com
Osteoarthritis Pipeline 2025: MOA And ROA Insights, Clinical Trials Status, And Key Companies Involved By Delveinsight Merck, Peptinov, LG Chem, Akan Bioscience, Biotissue,Inc., Eupraxia Pharma - Menafn.com
Momentum Shift: Does Ainos Inc have strong fundamentalsPortfolio Value Report & Risk Controlled Swing Trade Alerts - baoquankhu1.vn
(EPRX.WT.A) Technical Data (EPRX.WT.A:CA) - Stock Traders Daily
Gains Report: Will APWS stock hit new highs in YEARQuarterly Trade Report & Community Verified Watchlist Alerts - baoquankhu1.vn
Shorts Report: Will Eupraxia Pharmaceuticals Inc stock hit new highs in YEARTrade Signal Summary & Verified Trade Idea Suggestions - baoquankhu1.vn
Eupraxia Pharmaceuticals (OTCMKTS:EPRXF) Trading Down 0.1% – Time to Sell? - Defense World
Market Overview: What is Eupraxia Pharmaceuticals Incs valuation compared to sectorMarket Activity Report & Community Verified Watchlist Alerts - baoquankhu1.vn
(EPRX) Daily Stock Insights (EPRX:CA) - Stock Traders Daily
(EPRX.WT.A) Dynamic Trading Report - Stock Traders Daily
Risk Report: Whats the beta of Eupraxia Pharmaceuticals Inc stock2025 Macro Impact & AI Powered Market Entry Strategies - baoquankhu1.vn
Targets Report: Is PNFP a top pick in the sectorJuly 2025 Trade Ideas & Capital Efficiency Focused Strategies - baoquankhu1.vn
(EPRX) Strategic Market Analysis (EPRX:CA) - Stock Traders Daily
Aug Retail: What are Eupraxia Pharmaceuticals Incs recent SEC filings showingWeekly Trade Report & Real-Time Volume Trigger Notifications - baoquankhu1.vn
Aug Catalysts: Will Eupraxia Pharmaceuticals Inc benefit from rising consumer demand2025 Market Overview & Smart Swing Trading Alerts - baoquankhu1.vn
(EPRX) Trading Advice (EPRX:CA) - Stock Traders Daily
Eupraxia Pharmaceuticals (NASDAQ:EPRX) Price Target Raised to $19.00 at Cantor Fitzgerald - Defense World
Cantor Fitzgerald Raises Eupraxia Pharmaceuticals (NASDAQ:EPRX) Price Target to $19.00 - MarketBeat
Cantor Fitzgerald raises Eupraxia Pharmaceuticals stock price target to $19 By Investing.com - Investing.com UK
Buyback Watch: Will Lumentum Holdings Inc be affected by tariffsJuly 2025 Technicals & Free Community Supported Trade Ideas - baoquankhu1.vn
Eupraxia Pharmaceuticals Inc. (NASDAQ:EPRX) Receives Average Rating of "Buy" from Analysts - MarketBeat
Eupraxia Pharmaceuticals (TSX:EPRX) Price Target Increased by 21.11% to 14.96 - Nasdaq
Short Interest in Eupraxia Pharmaceuticals Inc. (NASDAQ:EPRX) Grows By 138.8% - MarketBeat
Eupraxia Pharmaceuticals (EPRX) Price Target Increased by 21.61% to 10.82 - Nasdaq
(EPRX.WT.A) Investment Performance Report - Stock Traders Daily
Trend Report: What is Eupraxia Pharmaceuticals Incs valuation compared to sectorMarket Trend Review & Free Accurate Trade Setup Notifications - baoquankhu1.vn
Trading Action: Will Eupraxia Pharmaceuticals Inc benefit from rising consumer demandMarket Trend Summary & High Conviction Buy Zone Picks - baoquankhu1.vn
Macro Review: Can Eupraxia Pharmaceuticals Inc grow without dilution2025 Institutional Moves & Safe Entry Momentum Stock Tips - baoquankhu1.vn
Trend Tracker for (EPRX) (EPRX:CA) - Stock Traders Daily
(EPRX) Trading Strategy and Analysis (EPRX:CA) - Stock Traders Daily
Can Eupraxia Pharmaceuticals Inc. stock sustain institutional interest2025 Key Highlights & Expert Verified Movement Alerts - Улправда
Eupraxia Pharmaceuticals’ (EPRX) Buy Rating Reaffirmed at HC Wainwright - Defense World
Eupraxia Pharmaceuticals (NASDAQ:EPRX) Given Buy Rating at HC Wainwright - MarketBeat
Eupraxia Pharmaceuticals Inc. (TSE:EPRX) surges 15%; retail investors who own 41% shares profited along with institutions - simplywall.st
Eupraxia Trial Data Shows Lasting Tissue Healing In Patients With Inflamed Esophagus - Sahm
Why Eupraxia Pharmaceuticals Inc. stock could benefit from AI revolution2025 Earnings Impact & AI Forecasted Entry/Exit Points - Улправда
What insider trading reveals about Eupraxia Pharmaceuticals Inc. stockWeekly Investment Summary & Smart Allocation Stock Tips - Улправда
Is Eupraxia Pharmaceuticals Inc. stock a buy on dips2025 Price Action Summary & Stepwise Trade Signal Guides - Улправда
Will Eupraxia Pharmaceuticals Inc. stock continue dividend increases2025 Big Picture & Consistent Growth Stock Picks - Улправда
How Eupraxia Pharmaceuticals Inc. stock reacts to inflationary pressuresJuly 2025 Trade Ideas & Capital Efficiency Focused Strategies - Улправда
(EPRX.WT.A) Investment Analysis and Advice - Stock Traders Daily
Eupraxia Pharmaceuticals Reports Positive Tissue Health Data from its Ongoing RESOLVE Trial in Eosinophilic Esophagitis Demonstrating Near-Complete Improvement on Biopsy - Investing News Network
Eupraxia Pharmaceuticals Announces Positive Tissue Health Data From Its Ongoing RESOLVE Trial - Nasdaq
Eupraxia Posts Strong Mid-Stage Data for Once-Yearly EoE Therapy EP-104GI - TipRanks
Eupraxia Pharmaceuticals reports positive tissue health data from its ongoing resolve trial - marketscreener.com
Eupraxia Pharmaceuticals Brief: Reporting "Positive" Tissue Health Data from its Ongoing RESOLVE Trial in Eosinophilic Esophagitis Demonstrating Near-Complete Improvement on Biopsy - marketscreener.com
Eupraxia Pharmaceuticals (OTCMKTS:EPRXF) Trading Up 0.3% – Here’s What Happened - Defense World
(EPRX.WT.A) Advanced Equity Analysis - Stock Traders Daily
0.23%
1.25%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):